In vitro experiments using the murine microglial BV2 cell line as well as in vivo experiments in mice demonstrate that exosomes carrying alpha-synuclein derived from PD patients enter microglia and induce activation, leading to enhanced microglial cytokine release and NO production [89]. This evidence concerns the gene SNCA and Parkinson disease.